Witnessing the stock’s movement on the chart, on Wednesday, Enovis Corp (NYSE: ENOV) set off with pace as it heaved 4.95% to $27.36, before settling in for the price of $26.07 at the close. Taking a more long-term approach, ENOV posted a 52-week range of $25.47-$49.38.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -4.65%. Meanwhile, its Annual Earning per share during the time was -4.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.26%. This publicly-traded company’s shares outstanding now amounts to $57.19 million, simultaneously with a float of $55.88 million. The organization now has a market capitalization sitting at $1.56 billion. At the time of writing, stock’s 50-day Moving Average stood at $29.86, while the 200-day Moving Average is $31.81.
Enovis Corp (ENOV) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Enovis Corp’s current insider ownership accounts for 2.28%, in contrast to 114.56% institutional ownership. According to the most recent insider trade that took place on Dec 09 ’25, this organization’s Former EVP, Strategy & Bus Dev sold 999 shares at the rate of 27.20, making the entire transaction reach 27,176 in total value, affecting insider ownership by 0. Preceding that transaction, on Dec 09 ’25, Company’s Former EVP, Strategy & Bus Dev sold 666 for 27.21, making the whole transaction’s value amount to 18,122. This particular insider is now the holder of 160,449 in total.
Enovis Corp (ENOV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.76 per share during the current fiscal year.
Enovis Corp’s EPS increase for this current 12-month fiscal period is 12.26% and is forecasted to reach 3.45 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.22% through the next 5 years, which can be compared against the -4.65% growth it accomplished over the previous five years trading on the market.
Enovis Corp (NYSE: ENOV) Trading Performance Indicators
Let’s observe the current performance indicators for Enovis Corp (ENOV). It’s Quick Ratio in the last reported quarter now stands at 1.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.70. Similarly, its price to free cash flow for trailing twelve months is now 68.72.
In the same vein, ENOV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -24.21, a figure that is expected to reach 0.82 in the next quarter, and analysts are predicting that it will be 3.45 at the market close of one year from today.
Technical Analysis of Enovis Corp (ENOV)
Going through the that latest performance of [Enovis Corp, ENOV]. Its last 5-days volume of 0.96 million was inferior to the volume of 1.08 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 28.59% While, its Average True Range was 45.74.
Raw Stochastic average of Enovis Corp (ENOV) in the period of the previous 100 days is set at 21.50%, which indicates a major fall in contrast to 34.01% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.25 that was higher than 1.19 volatility it exhibited in the past 100-days period.
